| 000 | 01478 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513204917.0 | ||
| 264 | 0 | _c20000427 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThiessard, F | |
| 245 | 0 | 0 |
_aPrognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). _h[electronic resource] |
| 260 |
_bCancer _cApr 2000 |
||
| 300 |
_a1696-702 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV Seropositivity _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtease Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMorlat, P | |
| 700 | 1 | _aMarimoutou, C | |
| 700 | 1 | _aLabouyrie, E | |
| 700 | 1 | _aRagnaud, J M | |
| 700 | 1 | _aPellegrin, J L | |
| 700 | 1 | _aDupon, M | |
| 700 | 1 | _aDabis, F | |
| 773 | 0 |
_tCancer _gvol. 88 _gno. 7 _gp. 1696-702 |
|
| 999 |
_c10691716 _d10691716 |
||